Yuanyi Intelligent
Chinese pharmaceutical 3D printing company developing DIW-based equipment and AI-supported drug-formulation development for personalized dosing.
- CEO / Founder
- Chen Peihong
- Team Size
- 1-10
- Stage
- Active
- Latest Round
- Bootstrapped
Technology & Products
Key Products
Four-channel DIW 3D printer; pharmaceutical DIW equipment; teaching-grade 3D printers; FDM and DLP equipment; powder binder-jetting equipment; 3D-printed drug and medical-device R&D services.
Technological Advantage
Self-developed multi-channel DIW equipment can print aqueous solutions, suspensions, gels, semisolids, elastomers, and other Newtonian and non-Newtonian materials at room temperature; the company combines this with a formulation-printability database and structure-release AI model.
Differentiation
Value Proposition
Combines DIW drug-printing hardware, formulation platforms, an excipient printability database, and structure-release AI models to develop drug products with controlled release time, rate, location, and dose.
How They Differentiate
Positions around DIW equipment and formulation-development services, rather than a single approved drug product, with a stated AI-driven structure-release formulation-design approach.
Market & Competition
Target Customers
Pharmaceutical researchers, drug-development organizations, medical-device researchers, and veterinary precision-dosing users.
Industry Verticals
Pharmaceutical R&D; personalized medicine; rare-disease treatment development; veterinary medicine; medical-device R&D.
Competitors
Triastek; Aprecia Pharmaceuticals; FabRx.
Growth & Milestones
Major Milestones
Founded in 2023; public patent application CN116674204A published in 2023.
Notable Customers
Chinese Academy of Sciences (Shanghai Institute of Ceramics); Wuhan Third Hospital; China Pharmaceutical University; Guangdong Pharmaceutical University (6+ universities and hospitals using their equipment as of 2023)